|
2013 Conference Publication A review of population pharmacokinetic and pharmacodynamic studies of mycophenolate in Autoimmune Disease patientsAbu Rahman, A. N., Tett, S. E. and Staatz, C. E. (2013). A review of population pharmacokinetic and pharmacodynamic studies of mycophenolate in Autoimmune Disease patients. Population Approach Group in Australia and New Zealand conference, Brisbane, QLD, Australia, February 2013. |
|
2013 Conference Publication Effect of the CYP3A5 6986A > G Polymorphism on Tacrolimus Pharmacokinetics in Liver Transplant Recipients: A Meta-analysisBuendia, J. A., Bramuglia, G. and Staatz, C. E. (2013). Effect of the CYP3A5 6986A > G Polymorphism on Tacrolimus Pharmacokinetics in Liver Transplant Recipients: A Meta-analysis. 13th International Congress of Therapeutic Drug Monitoring and Clinical Toxicology, Salt Lake City Ut, 22-26 September 2013. Philadelphia, PA United States: Lippincott Williams and Wilkins. doi: 10.1097/FTD.0b013e3182a8ef2b |
|
2013 Conference Publication Identification of continuous covariate relationshipsStørset, Elisabet, Staatz, Christine, Hennig, Stefanie, Bergmann, Troels K. and Holford, Nick (2013). Identification of continuous covariate relationships. 15th Annual Population Approach Group Australia and New Zealand Meeting (PAGANZ 2013), Brisbane, QLD, Australia, 13-15 February 2013. |
|
2013 Conference Publication A population pharmacokinetic model of tacrolimus in adult kidney transplant recipients.Bergmann, T. K., Hennig, S., Barraclough, K. A., Isbel, N. M. and Staatz, C. E. (2013). A population pharmacokinetic model of tacrolimus in adult kidney transplant recipients.. Annual meeting of the Danish Society of Pharmacology conference, Odense, Denmark, January 2013. |
|
2013 Journal Article Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting Dose.Bergman, Troels K., Hennig, Stefanie, Barraclough, Katherine A., Isbe,l Nicole M. and Staatz, Christine E. (2013). Population Pharmacokinetics of Tacrolimus in Adult Kidney Transplant Patients: Impact of CYP3A5 Genotype on Starting Dose.. Therapeutic Drug Monitoring, 36 (1), 62-70. doi: 10.1097/FTD.0b013e31829f1ab8 |
|
2012 Journal Article Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first weekBarraclough, Katherine A., Staatz, Christine E., Johnson, David W., Lee, Katie J., McWhinney, Brett C., Ungerer, Jacobus P. J., Hawley, Carmel M., Campbell, Scott B., Leary, Diana R. and Isbel, Nicole M. (2012). Kidney transplant outcomes are related to tacrolimus, mycophenolic acid and prednisolone exposure in the first week. Transplant International, 25 (11), 1182-1193. doi: 10.1111/j.1432-2277.2012.01553.x |
|
2012 Journal Article NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantationBarraclough, Katherine A., Isbel, Nicole M., Lee, Katie J., Bergmann, Troels K., Johnson, David W., McWhinney, Brett C., Ungerer, Jacobus P. J., Campbell, Scott B., Leary, Diana R., Bialasiewicz, Seweryn, Rockett, Rebecca J. and Staatz, Christine E. (2012). NR1I2 polymorphisms are related to tacrolimus dose-adjusted exposure and BK viremia in adult kidney transplantation. Transplantation, 94 (10), 1025-1032. doi: 10.1097/TP.0b013e31826c3985 |
|
2012 Journal Article A limited sampling strategy for the simultaneous estimation of tacrolimus, mycophenolic acid and unbound prednisolone exposure in adult kidney transplant recipientsBarraclough, Katherine A., Isbel, Nicole M., Johnson, David W., Hawley, Carmel M., Lee, Katie J., Mcwhinney, Brett C., Ungerer, Jacobus P., Campbell, Scott B., Leary, Diana R. and Staatz, Christine E. (2012). A limited sampling strategy for the simultaneous estimation of tacrolimus, mycophenolic acid and unbound prednisolone exposure in adult kidney transplant recipients. Nephrology, 17 (3), 294-299. doi: 10.1111/j.1440-1797.2011.01560.x |
|
2012 Conference Publication Pharmacokinetics of tobramycin do not differ in patients with and without cystic fibrosisHennig, Stefanie, Standing, Joseph, Staatz, Christine and Thompson, Alison (2012). Pharmacokinetics of tobramycin do not differ in patients with and without cystic fibrosis. Annual Meeting of the Population Approach Group in Europe, Venice, Italy, 5-8 June 2012. |
|
2012 Journal Article Clinical Pharmacokinetics and Pharmacodynamics of Prednisolone and Prednisone in Solid Organ TransplantationBergmann, Troels K., Barraclough, Katherine A., Lee, Katie J. and Staatz, Christine E. (2012). Clinical Pharmacokinetics and Pharmacodynamics of Prednisolone and Prednisone in Solid Organ Transplantation. Clinical Pharmacokinetics, 51 (11), 711-741. doi: 10.1007/s40262-012-0007-8 |
|
2012 Journal Article Continuous infusion vs. bolus dosing: Implications for beta-lactam antibioticsAbdul-Aziz, Mohd Hafiz, Staatz, C. E., Kirkpatrick, C. M. J., Lipman, J. and Roberts, J. A. (2012). Continuous infusion vs. bolus dosing: Implications for beta-lactam antibiotics. Minerva Anestesiologica, 78 (1), 94-104. |
|
2012 Conference Publication The impact of proton pump inhibitor co-medication on mycophenolic acid exposure early post-kidney transplantBarraclough, K., Isbel, N., Lee, K., Johnson, D., Campbell, S., Leary, D. and Staatz, C. (2012). The impact of proton pump inhibitor co-medication on mycophenolic acid exposure early post-kidney transplant. 48th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Auckland, New Zealand, 27-29 August 2012. Richmond, VIC, Australia: Wiley-Blackwell. |
|
2012 Conference Publication Prediction correction: quick fix for VPC misdiagnosis in a tacrolimus popPK modelBergmann, Troels, Hennig, Stefanie, Barraclough, Katherine and Staatz, Christine (2012). Prediction correction: quick fix for VPC misdiagnosis in a tacrolimus popPK model. PAGANZ 2012, Melbourme, Australia, 6 - 8 February 2012. |
|
2012 Conference Publication An impact of Nr1I2 genotype on dose-adjusted exposure to tacrolimus and Bk Viraemia in adult kidney transplantationBarraclough, K., Isbel, N., Lee, K., Bergmann, T., Johnson, D., Mcwhinney, B., Ungerer, J., Campbell, S., Leary, D., Bialasiewicz, S., Rockett, R. and Staatz, C. (2012). An impact of Nr1I2 genotype on dose-adjusted exposure to tacrolimus and Bk Viraemia in adult kidney transplantation. 48th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Auckland New Zealand, 27-29 August 2012. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2012.01631.x |
|
2011 Journal Article Population pharmacokinetics of tacrolimus in pediatric liver transplantation: Early posttranplantation clearanceWallin, Johan E., Bergstrand, Martin, Wilczek, Henryk E., Nydert, Per S., Karlsson, Mats O. and Staatz, Christine E. (2011). Population pharmacokinetics of tacrolimus in pediatric liver transplantation: Early posttranplantation clearance. Therapeutic Drug Monitoring, 33 (6), 663-672. doi: 10.1097/FTD.0b013e31823415cc |
|
2011 Journal Article Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipientsBarraclough, Katherine A, Isbel, Nicole M., McWhinney, Brett C., Ungerer, Jacobus P. J., Medley, Gregory, Johnson, David W., Hawley, Carmel M., Leary, Diana R., Campbell, Scott B. and Staatz, Christine E. (2011). Evaluation of limited sampling strategies for total and free prednisolone in adult kidney transplant recipients. European Journal of Clinical Pharmacology, 67 (12), 1243-1252. doi: 10.1007/s00228-011-1071-y |
|
2011 Journal Article Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?Staatz, Christine E. and Tett, Susan E. (2011). Maximum a posteriori bayesian estimation of mycophenolic acid area under the concentration-time curve: Is this clinically useful for dosage prediction yet?. Clinical Pharmacokinetics, 50 (12), 759-772. doi: 10.2165/11596380-000000000-00000 |
|
2011 Journal Article Once- versus twice-daily tacrolimus: Are the formulations truly equivalent?Barraclough, Katherine A, Isbel, Nicole M., Johnson, David W., Campbell, Scott B. and Staatz, Christine E. (2011). Once- versus twice-daily tacrolimus: Are the formulations truly equivalent?. Drugs, 71 (12), 1561-1577. doi: 10.2165/11593890-000000000-00000 |
|
2011 Journal Article Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposureTett, Susan E., Saint-Marcoux, Franck, Staatz, Christine E., Brunet, Merce, Vinks, Alexander A., Miura, Masatomo, Marquet, Pierre, Kuypers, Dirk R., van Gelder, Teun and Cattaneo, Dario (2011). Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure. Transplantation Reviews, 25 (2), 47-57. doi: 10.1016/j.trre.2010.06.001 |
|
2011 Journal Article Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipientsBarraclough, KA, Isbel, NM, Kirkpatrick, CM, Lee, KJ, Taylor, PJ, Johnson, DW, Campbell, SB, Leary, DR and Staatz, CE (2011). Evaluation of limited sampling methods for estimation of tacrolimus exposure in adult kidney transplant recipients. British Journal of Clinical Pharmacology, 71 (2), 207-223. doi: 10.1111/j.1365-2125.2010.03815.x |
